B
BioSante Pharmaceuticals
Pharmacy Health | Information for Great Healthcare
About BioSante Pharmaceuticals
Biosante Pharmaceuticals operates in the biotechnology and pharmaceutical sectors, focusing on developing innovative treatments for major healthcare challenges. The company serves a diverse range of clients, including healthcare providers, insurers, and research institutions. Operating primarily in the U.S. market, Biosante Pharmaceuticals leverages cutting-edge biotechnology to create solutions for diseases such as HIV, coronavirus, and other critical health issues. The business model revolves around research and development, clinical trials, and partnerships with governmental and private entities to bring new medications to market. Revenue is generated through the sale of proprietary medications, licensing agreements, and collaborations with health insurers and research organizations.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 1996
- Headquarters
- Lincolnshire, United States
- Employees
- 12
- Open positions
- None listed
- Dealroom signal
- 41.7/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Pharmacy, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2C
Knowledge graph
News
More headlines
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jun 2013 | $0 | — | ANI Pharmaceuticals | — |
| ACQUISITION✓Exit | Oct 2012 | $0 | — | ANI Pharmaceuticals | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for BioSante Pharmaceuticals is 1.3K monthly website visits, up 18.2% over the last three months. BioSante Pharmaceuticals's team grew 9.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
BioSante Pharmaceuticals in the Lincolnshire ecosystem
The BioSante Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Great Point Partners
Other known investors1 additional known investor
ANI Pharmaceuticals
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about BioSante Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BioSante Pharmaceuticals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.